Skip Nav Destination
Issues
Research Articles
A Comparison between Real-Time Polymerase Chain Reaction and Hybrid Capture 2 for Human Papillomavirus DNA Quantitation1
Patti E. Gravitt; Robert D. Burk; Attila Lorincz; Rolando Herrero; Allan Hildesheim; Mark E. Sherman; Maria Concepcion Bratti; Ana Cecilia Rodriguez; Kathy J. Helzlsouer; Mark Schiffman
Short Communications
Null Results in Brief
Letters to the Editor
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.